Drug Shortage Report for PRIORIX

Last updated on 2019-07-13 History
Report ID 82762
Drug Identification Number 02239208
Brand name PRIORIX
Common or Proper name Combined measles, mumps and rubella vaccine, live, attenuated
Company Name GLAXOSMITHKLINE INC
Active Ingredient(s) MUMPS VIRUS VACCINE LIVE ATTENUATED RUBELLA VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED WATER
Strength(s) 10000UNIT 1000UNIT 1000UNIT 0.5ML
Dosage form(s) KIT POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS INTRAMUSCULAR
Packaging size 10's
ATC code J07BD
ATC description VIRAL VACCINES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2019-04-24
Estimated end date 2019-07-12
Actual end date 2019-07-12
Shortage status Resolved
Updated date 2019-07-13
Company comments Delay in supply of GSK Diluent (packs of 10s) required for use with vaccine. Alternate supply of GSK Diluent available in packs of 100.
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2019-07-13 English Compare
v6 2019-07-12 French Compare
v5 2019-07-12 English Compare
v4 2019-05-23 French Compare
v3 2019-05-23 English Compare
v2 2019-04-29 French Compare
v1 2019-04-29 English Compare